Alexion Pharmaceuticals, Inc. ALXN

Alexion Pharmaceuticals, Inc. DIO Ratio 2011-2026 | ALXN

Annual DIO Ratio Alexion Pharmaceuticals, Inc.

2020	2019	2018	2017	2016	2015	2014	2013	2012	2011
512	581	461	370	531	454	370	211	474	319

All numbers in USD currency

Indicator range from annual reports

Maximum	Minimum	Average
581	211	428

DIO Ratio of other stocks in the Biotechnology industry

	Issuer	DIO Ratio	Price	% 24h	Market Cap	Country
	Heron Therapeutics HRTX	644	$ 0.8	2.7 %	$ 133 M	USA
	Amphastar Pharmaceuticals AMPH	166	$ 19.23	-1.38 %	$ 899 M	USA
	Aytu BioScience AYTU	209	$ 2.63	0.77 %	$ 16.5 M	USA
	Midatech Pharma plc MTP	40.6	-	-18.52 %	$ 27.3 M	Britain
	Incyte Corporation INCY	78.4	$ 90.45	-0.36 %	$ 17.7 B	USA
	Aeterna Zentaris AEZS	55.6	-	5.93 %	$ 314 M	Canada
	Acorda Therapeutics ACOR	345	-	-24.86 %	$ 820 K	USA
	Albireo Pharma ALBO	26.1	-	-0.23 %	$ 916 M	USA
	Acasti Pharma ACST	136	-	4.01 %	$ 150 M	Canada
	Институт стволовых клеток человека ISKJ	275	-	-	-	Russia
	BioDelivery Sciences International BDSI	321	-	-4.8 %	$ 255 M	USA
	BeiGene, Ltd. BGNE	304	-	0.49 %	$ 251 B	Cayman-islands
	Kamada Ltd. KMDA	166	$ 8.2	-0.61 %	$ 260 M	Israel
	Karyopharm Therapeutics KPTI	52.5	$ 6.66	-12.71 %	$ 812 K	USA
	Clovis Oncology CLVS	271	-	-7.23 %	$ 13 M	USA